| Literature DB >> 33115721 |
Cody M Rogers1, Elsbeth Sanders1, Phoebe A Nguyen1, Whitney Smith-Kinnaman2, Amber L Mosley2, Matthew L Bochman3.
Abstract
The human genome encodes five RecQ helicases (RECQL1, BLM, WRN, RECQL4, and RECQL5) that participate in various processes underpinning genomic stability. Of these enzymes, the disease-associated RECQL4 is comparatively understudied due to a variety of technical challenges. However, Saccharomyces cerevisiae encodes a functional homolog of RECQL4 called Hrq1, which is more amenable to experimentation and has recently been shown to be involved in DNA inter-strand crosslink (ICL) repair and telomere maintenance. To expand our understanding of Hrq1 and the RecQ4 subfamily of helicases in general, we took a multi-omics approach to define the Hrq1 interactome in yeast. Using synthetic genetic array analysis, we found that mutations of genes involved in processes such as DNA repair, chromosome segregation, and transcription synthetically interact with deletion of HRQ1 and the catalytically inactive hrq1 -K318A allele. Pull-down of tagged Hrq1 and mass spectrometry identification of interacting partners similarly underscored links to these processes and others. Focusing on transcription, we found that hrq1 mutant cells are sensitive to caffeine and that mutation of HRQ1 alters the expression levels of hundreds of genes. In the case of hrq1 -K318A, several of the most highly upregulated genes encode proteins of unknown function whose expression levels are also increased by DNA ICL damage. Together, our results suggest a heretofore unrecognized role for Hrq1 in transcription, as well as novel members of the Hrq1 ICL repair pathway. These data expand our understanding of RecQ4 subfamily helicase biology and help to explain why mutations in human RECQL4 cause diseases of genomic instability.Entities:
Keywords: DNA helicase; Hrq1; RecQ; Saccharomyces cerevisiae; transcription
Year: 2020 PMID: 33115721 PMCID: PMC7718736 DOI: 10.1534/g3.120.401864
Source DB: PubMed Journal: G3 (Bethesda) ISSN: 2160-1836 Impact factor: 3.154
Strains used in this study
| Name | Genotype | Source |
|---|---|---|
| Y8205 | ( | |
| YPH499 | ( | |
| MBY346 | ( | |
| MBY520 | This study | |
| MBY639 | This study | |
| MBY644 | This study |
Gene Ontology (GO) Term enrichment of negative genetic interactors with hrq1
| GO Term (GO ID) | Genes Annotated to the GO Term | GO Term Usage in Gene List | Genome Frequency of Use |
|---|---|---|---|
| transcription by RNA polymerase II (GO:0006366) | ABF1, CDC28, CDC73, CEG1, CSE2, EAF7, ESS1, GIM3, HMO1, HTZ1, MED11, NAB3, NUT1, RAD4, SDS3, SGF73, SIN3, SPT15, SPT3, SPT8, SRB2, SRB6, STH1, SUA7, SWI4, TAF11, TAF2, YJR084W | 28 of 191 genes, 14.66% | 536 of 6436 annotated genes, 8.33% |
| regulation of organelle organization (GO:0033043) | APC4, BDF2, CDC15, CDC20, CDC28, CDC73, CTI6, DAM1, EFB1, ESS1, GIC1, LTE1, MOB1, PEF1, PSE1, SDS3, SIN3, SPO16, TGS1, UTH1, VPS41 | 21 of 191 genes, 10.99% | 326 of 6436 annotated genes, 5.07% |
| DNA repair (GO:0006281) | ABF1, ACT1, BDF2, CDC28, CDC73, CST9, EAF7, NSE4, NSE5, POL1, PRP19, RAD14, RAD33, RAD4, RAD52, RAD54, RAD59, RNH201, RTT107, SIN3, STH1 | 21 of 191 genes, 10.99% | 300 of 6436 annotated genes, 4.66% |
| chromatin organization (GO:0006325) | ABF1, BDF2, CDC28, CLP1, CTI6, EAF7, ESS1, GIC1, HTZ1, LGE1, RAD54, SDS3, SGF73, SIN3, SIR1, SPT3, SPT8, STH1, SWC5, UTH1, YCS4 | 21 of 191 genes, 10.99% | 310 of 6436 annotated genes, 4.82% |
| mitotic cell cycle (GO:0000278) | ACT1, APC4, CDC10, CDC15, CDC20, CDC25, CDC28, CDC34, DAM1, GIC1, LTE1, MOB1, PEF1, POL1, PSE1, SIC1, SIN3, SWI4, TUB2, YCS4 | 20 of 191 genes, 10.47% | 373 of 6436 annotated genes, 5.80% |
| peptidyl-amino acid modification (GO:0018193) | ACT1, APJ1, CDC15, CDC28, CDC73, CST9, DBF2, EAF7, ESS1, LIP5, NSE4, NSE5, PSE1, SGF73, SMT3, SPO16, SPT3, SPT8, SWF1, TDA1 | 20 of 191 genes, 10.47% | 244 of 6436 annotated genes, 3.79% |
| cytoskeleton organization (GO:0007010) | ACT1, BBP1, CDC10, CDC15, CDC28, CDC31, CMD1, CTF13, DAM1, EFB1, ENT1, ENT3, GIC1, NDC1, SPC29, STH1, SWF1, TUB2 | 18 of 191 genes, 9.42% | 272 of 6436 annotated genes, 4.23% |
| mitochondrion organization (GO:0007005) | ACT1, ATG1, ATG3, COA4, FCJ1, MDM35, PAM16, PAM17, PHB2, PTC1, QCR2, RCF2, SAM37, TIM18, TOM70, UTH1, YJR120W, YME1 | 18 of 191 genes, 9.42% | 279 of 6436 annotated genes, 4.33% |
| organelle fission (GO:0048285) | APC4, CDC10, CDC15, CDC20, CDC28, CST9, DAM1, DBF2, EBP2, GIC1, LTE1, MOB1, PSE1, RAD52, SPO16, TUB2, YCS4 | 17 of 191 genes, 8.90% | 268 of 6436 annotated genes, 4.16% |
| response to chemical (GO:0042221) | ACT1, ASK10, GIM3, GPR1, IRA2, MUP3, PTC1, SRB2, TDA1, TIM18, TMA19, TUB2, VPS27, YJR084W, YLR225C, YOS9 | 16 of 191 genes, 8.38% | 567 of 6436 annotated genes, 8.81% |
Gene Ontology (GO) Term enrichment of positive genetic interactors with hrq1
| GO Term (GO ID) | Genes Annotated to the GO Term | GO Term Usage in Gene List | Genome Frequency of Use |
|---|---|---|---|
| mitotic cell cycle (GO:0000278) | ACT1, APC11, BRN1, CDC48, CDC6, CLB3, CSM1, DPB11, IPL1, MCD1, MPS1, MPS3, MYO2, PDS5, PFY1, PSE1, PSF1, SMC4, SPT6, VRP1 | 20 of 151 genes, 13.25% | 373 of 6436 annotated genes, 5.80% |
| cytoskeleton organization (GO:0007010) | ACT1, AIM14, ARP3, CDC48, CLB3, ICE2, IPL1, LAS17, MPS1, MPS2, MPS3, MYO2, NUM1, PFY1, RSP5, SPC29, STH1, TSC11, VRP1 | 19 of 151 genes, 12.58% | 272 of 6436 annotated genes, 4.23% |
| regulation of organelle organization (GO:0033043) | AIM14, APC11, ARP3, CDC48, CDC6, CLB3, IPL1, LAS17, MPS1, PCP1, PFY1, PSE1, RSP5, SEC23, SGV1, SPT6, TSC11, VRP1 | 18 of 151 genes, 11.92% | 326 of 6436 annotated genes, 5.07% |
| lipid metabolic process (GO:0006629) | ALG14, CDC1, CHO2, DGA1, GAA1, GPI10, GPI12, GPI2, GWT1, LCB1, MGA2, OPI3, PHS1, RSP5, SAC1, SUR1, TSC11, VPS4 | 18 of 151 genes, 11.92% | 347 of 6436 annotated genes, 5.39% |
| DNA repair (GO:0006281) | ACT1, ARP8, CDC1, DPB11, IXR1, MCD1, NHP10, PDS5, POB3, POL3, PSF1, RAD3, RNH201, RSC2, SLX5, SLX8, STH1, TEL1 | 18 of 151 genes, 11.92% | 300 of 6436 annotated genes, 4.66% |
| transcription by RNA polymerase II (GO:0006366) | CAM1, CSE2, IXR1, MGA2, MOT1, NHP10, PDC2, POB3, RAD3, RGR1, RSC2, RSP5, SGV1, SPT6, STH1 | 15 of 151 genes, 9.93% | 536 of 6436 annotated genes, 8.33% |
| chromatin organization (GO:0006325) | ARP8, CAC2, CDC6, IES1, MGA2, MPS3, NHP10, ORC6, POB3, RSC2, RSP5, SPT6, STH1, TEL1 | 14 of 151 genes, 9.27% | 310 of 6436 annotated genes, 4.82% |
| chromosome segregation (GO:0007059) | APC11, BRN1, CDC48, CSM1, IPL1, MCD1, MPS1, MPS3, PDS5, RSC2, SMC4, SPC24, STH1 | 13 of 151 genes, 8.61% | 210 of 6436 annotated genes, 3.26% |
| organelle fission (GO:0048285) | APC11, BRN1, CLB3, CSM1, IPL1, MCD1, MPS1, MPS3, NUM1, PDS5, PSE1, SMC4 | 12 of 151 genes, 7.95% | 268 of 6436 annotated genes, 4.16% |
| rRNA processing (GO:0006364) | BMS1, FAL1, MAK5, MOT1, MRM2, POP4, RPF2, RPS23A, RPS6B, RPS9B, RSP5, SLX9 | 12 of 151 genes, 7.95% | 352 of 6436 annotated genes, 5.47% |
Figure 1Identification of the Hrq1-3xFLAg interactome by IP-MS and SAINT. A) Overview of the 290 interactions identified by SAINT in anti-FLAG Hrq1 purifications. The graph compares the FC-B score against the SAINT probability score. The dashed line represents the 0.75 probability cut-off. The highest confidence hit, Hrq1, is shown in red. Subsets of the 290 interactors enriched for rRNA processing and ribosomal small subunit biogenesis (B), transcription by RNA polymerase I (C), and transcription by RNA polymerase II (D) factors are also shown. Members of macromolecular complexes associated with these processes are labeled and color coded: small ribosomal subunit processome (https://www.yeastgenome.org/complex/CPX-1604), green; RNA polymerase I (https://www.yeastgenome.org/complex/CPX-1664), II (https://www.yeastgenome.org/complex/CPX-2662), and III (https://www.yeastgenome.org/go/GO:0005666), red; PAF1 complex (https://www.yeastgenome.org/complex/CPX-1726), purple; casein kinase 2 (https://www.yeastgenome.org/complex/CPX-581), blue; UTP-A complex (https://www.yeastgenome.org/complex/CPX-1409), orange; and TFIID (https://www.yeastgenome.org/complex/CPX-1642), teal. All identifiers for these data are included in Table S6.
Gene Ontology (GO) Term enrichment of proteins that physically interact with Hrq1
| GO Term (GO ID) | Genes Annotated to the GO Term | GO Term Usage in Gene List | Genome Frequency of Use |
|---|---|---|---|
| rRNA processing (GO:0006364) | BMS1, BUD21, CBF5, CIC1, DBP10, DBP3, DBP9, DHR2, DIP2, ECM16, ENP2, ERB1, ESF1, FUN12, GAR1, KRE33, MAK5, MOT1, MPP10, MRD1, NHP2, NOP56, NOP8, NSA2, NSR1, NUG1, RLP7, ROK1, RPL1A, RPS6A, RPS8A, RRP12, RRP8, TSR1, URB1, UTP10, UTP22, UTP9 | 38 of 75 genes, 50.67% | 352 of 6436 annotated genes, 5.47% |
| ribosomal small subunit biogenesis (GO:0042274) | BMS1, BUD21, DHR2, DIP2, ECM16, ENP2, FUN12, KRE33, MPP10, MRD1, NSR1, ROK1, RPS19A, RPS6A, RPS8A, RRP12, SGD1, TSR1, UTP10, UTP22, UTP9 | 21 of 75 genes, 28.00% | 149 of 6436 annotated genes, 2.32% |
| ribosomal large subunit biogenesis (GO:0042273) | CIC1, DBP10, DBP3, DBP9, ERB1, MAK5, NHP2, NOC2, NOP8, NSA2, NUG1, RIX7, RLP7, RPL12A, RPL1A, RRP8, SDA1, URB1 | 18 of 75 genes, 24.00% | 122 of 6436 annotated genes, 1.90% |
| cytoplasmic translation (GO:0002181) | FUN12, NIP1, RPL12A, RPL1A, RPL23A, RPL43A, RPS19A, RPS25B, RPS6A, RPS8A | 10 of 75 genes, 13.33% | 201 of 6436 annotated genes, 3.12% |
| transcription by RNA polymerase I (GO:0006360) | CDC73, CTR9, DHR2, LEO1, MOT1, RPA49, RPB5, UTP10, UTP9 | 9 of 75 genes, 12.00% | 69 of 6436 annotated genes, 1.07% |
| transcription by RNA polymerase II (GO:0006366) | CDC73, CTR9, HHF1, HTA1, LEO1, MOT1, RPB5, RTG3 | 8 of 75 genes, 10.67% | 536 of 6436 annotated genes, 8.33% |
| RNA modification (GO:0009451) | AIR2, CBF5, GAR1, KRE33, NHP2, NOP56, PUS1, RRP8 | 8 of 75 genes, 10.67% | 177 of 6436 annotated genes, 2.75% |
| DNA repair (GO:0006281) | CDC73, CTR9, HTA1, LEO1, PDS5, RFC3 | 6 of 75 genes, 8.00% | 300 of 6436 annotated genes, 4.66% |
| chromatin organization (GO:0006325) | CTR9, FPR3, FPR4, HHF1, HTA1, LEO1 | 6 of 75 genes, 8.00% | 310 of 6436 annotated genes, 4.82% |
| peptidyl-amino acid modification (GO:0018193) | CDC73, CTR9, FPR3, FPR4, HHF1, LEO1 | 6 of 75 genes, 8.00% | 244 of 6436 annotated genes, 3.79% |
Figure 2Mutation of affects transcription. A) Tenfold serial dilutions of the indicated strains on rich medium (YPD) and YPD containing 10 mM caffeine. The -K318A cells are more sensitive to caffeine than the mild sensitivity displayed by the Δ mutant. B) Quantitative analysis of the effects of caffeine on the growth of cells. The normalized values were averaged from 3 3 independent experiments and compared to wild-type growth at the same caffeine concentration by one-way ANOVA. **, P < 0.001 and ***, P < 0.0001. As in (A), Δ cells display milder sensitivity to caffeine than -k318A cells. C) Analysis of the distribution of the magnitudes of expression changes of the DEGs. The log2 fold change data for the significantly downregulated (Down) and upregulated (Up) DEGs in Δ and -K318A cells compared to wild-type cells are shown as box and whisker plots drawn using the Tukey method. The individually plotted points outside of the inner fences represent outliers (i.e., expression changes with the largest absolute values) and correspond to genes whose log2 fold change value is less than the value of the 25th quartile minus 1.5 times the inter-quartile distance (IQR) for downregulation or genes whose log2 fold change value is greater than the value of the 75th quartile plus 1.5IQR for upregulation.